COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 33273024.
- Also identified by DOI 10.1136/thoraxjnl-2020-216083.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hospitalisations for acute exacerbations of COPD (AECOPD) carry significant morbidity and mortality. Respiratory viral infections (RVIs) are the most common cause of AECOPD and are associated with worse clinical outcomes. During the COVID-19 pandemic, public health measures, such as social distancing and universal masking, were originally implemented to reduce transmission of SARS-CoV-2; these public health measures were subsequently also observed to reduce transmission of other common circulating RVIs. In this study, we report a significant and sustained decrease in hospital admissions for all AECOPD as well as RVI-associated AECOPD, which coincided with the introduction of public health measures during the COVID-19 pandemic.
Medical subject headings
- COVID-19
- Hospitalization
- Hospitals
- Pandemics
- Public Health